Entera Bio (ENTX) Shares Outstanding (Weighted Average) (2017 - 2026)

Entera Bio has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $47.8 million for Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 10.1% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.8 million (up 10.1% YoY) and the FY2025 annual result came in at $46.2 million, up 22.68% from the prior year.
• Shares Outstanding (Weighted Average) rose to $47.8 million in Q1 2026, from $46.2 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $47.8 million in Q1 2026 and troughed at $28.8 million in Q1 2022.
• A 5-year average of $35.7 million and a median of $36.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 31.59% — and 2023, when it grew 0.01%.
• Tracing ENTX's Shares Outstanding (Weighted Average) over 5 years: stood at $28.8 million in 2022, then climbed by 0.69% to $29.0 million in 2023, then climbed by 29.79% to $37.7 million in 2024, then grew by 22.68% to $46.2 million in 2025, then grew by 3.39% to $47.8 million in 2026.
• Business Quant data shows ENTX's Shares Outstanding (Weighted Average) at $47.8 million in Q1 2026, $46.2 million in Q4 2025, and $45.8 million in Q3 2025.